Literature DB >> 21518762

Chemical modifications in therapeutic protein aggregates generated under different stress conditions.

Quanzhou Luo1, Marisa K Joubert, Riki Stevenson, Randal R Ketchem, Linda O Narhi, Jette Wypych.   

Abstract

In this study, we characterized the chemical modifications in the monoclonal antibody (IgG(2)) aggregates generated under various conditions, including mechanical, chemical, and thermal stress treatment, to provide insight into the mechanism of protein aggregation and the types of aggregate produced by the different stresses. In a separate study, additional biophysical characterization was performed to arrange these aggregates into a classification system (Joubert, M. K., Luo, Q., Nashed-Samuel, Y., Wypych, J., and Narhi, L. O. (2011) J. Biol. Chem. 286, 25118-25133). Here, we report that different aggregates possessed different types and levels of chemical modification. For chemically treated samples, metal-catalyzed oxidation using copper showed site-specific oxidation of Met(246), His(304), and His(427) in the Fc portion of the antibody, which might be attributed to a putative copper-binding site. For the hydrogen peroxide-treated sample, in contrast, four solvent-exposed Met residues in the Fc portion were completely oxidized. Met and/or Trp oxidation was observed in the mechanically stressed samples, which is in agreement with the proposed model of protein interaction at the air-liquid interface. Heat treatment resulted in significant deamidation but almost no oxidation, which is consistent with thermally induced aggregates being generated by a different pathway, primarily by perturbing conformational stability. These results demonstrate that chemical modifications are present in protein aggregates; furthermore, the type, locations, and severity of the modifications depend on the specific conditions that generated the aggregates.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21518762      PMCID: PMC3137086          DOI: 10.1074/jbc.M110.160440

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  46 in total

1.  The effects of alpha-helix on the stability of Asn residues: deamidation rates in peptides of varying helicity.

Authors:  A A Kosky; U O Razzaq; M J Treuheit; D N Brems
Journal:  Protein Sci       Date:  1999-11       Impact factor: 6.725

2.  Antibodies have the intrinsic capacity to destroy antigens.

Authors:  A D Wentworth; L H Jones; P Wentworth; K D Janda; R A Lerner
Journal:  Proc Natl Acad Sci U S A       Date:  2000-09-26       Impact factor: 11.205

3.  Mechanisms of metal-catalyzed oxidation of histidine to 2-oxo-histidine in peptides and proteins.

Authors:  C Schöneich
Journal:  J Pharm Biomed Anal       Date:  2000-01       Impact factor: 3.935

Review 4.  Mass spectrometry for structural characterization of therapeutic antibodies.

Authors:  Zhongqi Zhang; Hai Pan; Xiaoyu Chen
Journal:  Mass Spectrom Rev       Date:  2009 Jan-Feb       Impact factor: 10.946

5.  Tungsten-induced protein aggregation: solution behavior.

Authors:  Yijia Jiang; Yasser Nashed-Samuel; Cynthia Li; Wei Liu; Joey Pollastrini; David Mallard; Zai-Qing Wen; Kiyoshi Fujimori; Monica Pallitto; Lisa Donahue; Grace Chu; Gianni Torraca; Aylin Vance; Tony Mire-Sluis; Erwin Freund; Janice Davis; Linda Narhi
Journal:  J Pharm Sci       Date:  2009-12       Impact factor: 3.534

6.  Classification and characterization of therapeutic antibody aggregates.

Authors:  Marisa K Joubert; Quanzhou Luo; Yasser Nashed-Samuel; Jette Wypych; Linda O Narhi
Journal:  J Biol Chem       Date:  2011-03-25       Impact factor: 5.157

7.  Precipitation of a monoclonal antibody by soluble tungsten.

Authors:  Jared S Bee; Stephanie A Nelson; Erwin Freund; John F Carpenter; Theodore W Randolph
Journal:  J Pharm Sci       Date:  2009-09       Impact factor: 3.534

8.  Human antibody Fc deamidation in vivo.

Authors:  Y Diana Liu; Jian Zhang van Enk; Gregory C Flynn
Journal:  Biologicals       Date:  2009-07-15       Impact factor: 1.856

9.  Methionine, tryptophan, and histidine oxidation in a model protein, PTH: mechanisms and stabilization.

Authors:  Junyan A Ji; Boyan Zhang; Wilson Cheng; Y John Wang
Journal:  J Pharm Sci       Date:  2009-12       Impact factor: 3.534

10.  Methionine oxidation in human IgG2 Fc decreases binding affinities to protein A and FcRn.

Authors:  Hai Pan; Kenneth Chen; Liping Chu; Francis Kinderman; Izydor Apostol; Gang Huang
Journal:  Protein Sci       Date:  2009-02       Impact factor: 6.725

View more
  45 in total

Review 1.  Silk-based stabilization of biomacromolecules.

Authors:  Adrian B Li; Jonathan A Kluge; Nicholas A Guziewicz; Fiorenzo G Omenetto; David L Kaplan
Journal:  J Control Release       Date:  2015-09-25       Impact factor: 9.776

Review 2.  Oxidation of therapeutic proteins and peptides: structural and biological consequences.

Authors:  Riccardo Torosantucci; Christian Schöneich; Wim Jiskoot
Journal:  Pharm Res       Date:  2013-09-25       Impact factor: 4.200

3.  Structural characterization of IgG1 mAb aggregates and particles generated under various stress conditions.

Authors:  Srivalli N Telikepalli; Ozan S Kumru; Cavan Kalonia; Reza Esfandiary; Sangeeta B Joshi; C Russell Middaugh; David B Volkin
Journal:  J Pharm Sci       Date:  2014-01-22       Impact factor: 3.534

4.  Radar chart array analysis to visualize effects of formulation variables on IgG1 particle formation as measured by multiple analytical techniques.

Authors:  Cavan Kalonia; Ozan S Kumru; Jae Hyun Kim; C Russell Middaugh; David B Volkin
Journal:  J Pharm Sci       Date:  2013-10-09       Impact factor: 3.534

5.  Classification and characterization of therapeutic antibody aggregates.

Authors:  Marisa K Joubert; Quanzhou Luo; Yasser Nashed-Samuel; Jette Wypych; Linda O Narhi
Journal:  J Biol Chem       Date:  2011-03-25       Impact factor: 5.157

6.  UV photodegradation of murine growth hormone: chemical analysis and immunogenicity consequences.

Authors:  Amber Haynes Fradkin; Olivier Mozziconacci; Christian Schöneich; John F Carpenter; Theodore W Randolph
Journal:  Eur J Pharm Biopharm       Date:  2014-04-20       Impact factor: 5.571

Review 7.  Structure, heterogeneity and developability assessment of therapeutic antibodies.

Authors:  Yingda Xu; Dongdong Wang; Bruce Mason; Tony Rossomando; Ning Li; Dingjiang Liu; Jason K Cheung; Wei Xu; Smita Raghava; Amit Katiyar; Christine Nowak; Tao Xiang; Diane D Dong; Joanne Sun; Alain Beck; Hongcheng Liu
Journal:  MAbs       Date:  2018-12-17       Impact factor: 5.857

8.  Biosimilarity under stress: A forced degradation study of Remicade® and Remsima™.

Authors:  Karthik Pisupati; Alexander Benet; Yuwei Tian; Solomon Okbazghi; Jukyung Kang; Michael Ford; Sergei Saveliev; K Ilker Sen; Eric Carlson; Thomas J Tolbert; Brandon T Ruotolo; Steven P Schwendeman; Anna Schwendeman
Journal:  MAbs       Date:  2017-08-08       Impact factor: 5.857

9.  Identification of oxidation sites and covalent cross-links in metal catalyzed oxidized interferon Beta-1a: potential implications for protein aggregation and immunogenicity.

Authors:  Riccardo Torosantucci; Victor S Sharov; Miranda van Beers; Vera Brinks; Christian Schöneich; Wim Jiskoot
Journal:  Mol Pharm       Date:  2013-05-02       Impact factor: 4.939

10.  Structural analysis of a therapeutic monoclonal antibody dimer by hydroxyl radical footprinting.

Authors:  Galahad Deperalta; Melissa Alvarez; Charity Bechtel; Ken Dong; Ross McDonald; Victor Ling
Journal:  MAbs       Date:  2012-12-17       Impact factor: 5.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.